In atypical SCLC (aSCLC)—a distinct subset characterized by the absence of RB1 and TP53 co-inactivation and by limited or no tobacco exposure—DLL3 expression closely parallels that of ASCL1 [67]. This evidence concerns the gene DLL3 and small cell lung carcinoma.